EGF receptor variant III as a target antigen for tumor immunotherapy (Q37259602)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on September 2008

Language	Label	Description	Also known as
English	EGF receptor variant III as a target antigen for tumor immunotherapy	scientific article published on September 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

EGF receptor variant III as a target antigen for tumor immunotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

based on heuristic

inferred from title

cancer immunotherapy

1 reference

based on heuristic

inferred from title

author name string

Gordon Li

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Albert J Wong

2

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

1 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Expert Review of Vaccines

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

977-985

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

EGF-ERBB signalling: towards the systems level

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

ERBB receptors and cancer: the complexity of targeted inhibitors

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

EGFR antagonists in cancer treatment

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Structural alterations of the epidermal growth factor receptor gene in human gliomas

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Constitutive Activation of c-Jun N-terminal Kinase by a Mutant Epidermal Growth Factor Receptor

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

The natural history of EGFR and EGFRvIII in glioblastoma patients

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Keyhole limpet hemocyanin (KLH): a biomedical review

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomas

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

EGF mutant receptor vIII as a molecular target in cancer therapy

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Targeting the epidermal growth factor receptor in high-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

RNA interference against a glioma-derived allele of EGFR induces blockade at G2M.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Impaired capacity for upregulation of MHC class II in tumor-associated microglia

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.977

21 January 2018

Identifiers

10.1586/14760584.7.7.977

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37259602&oldid=2233863492"